Bio-Pharma
TLRC, a TBRC company, delivers comprehensive bio-pharma industry insights. Our expertise includes both small molecules and biologics.
With a commitment to actionable intelligence, TLRC empowers clients with insights into groundbreaking developments, regulatory landscapes, and market opportunities
Download Our Latest Decks Here
Pipeline Drug Analysis of CAR-T Therapy Drugs
Global Protein Labeling With Bio-Imager Market
Dairy Farming and Mastitis Treatment Market Study
Adoption Of Advanced Technologies
Professional services firms leverage advanced research tech for consumer insights. Market research firms offer eye-tracking tech for unbiased insights. Tech advances drive biotech and mechanics discoveries, fueling design, research, and consulting services.
Gene Therapy is Driving Transformative Results
In the past two decades, gene therapy adoption has surged, driven by research advancements targeting cancers, neurodegenerative disorders, and genetic diseases. TBRC offers crucial support to biopharma firms, aiding in understanding needs, processes, benchmarks, and market insights.
Dynamic and Evolving Biologics Regulation
As many countries are updating their regulatory guidelines pertaining to biologics approval pathways, TBRC can help biologic manufacturers with custom projects on regulatory landscape of biologics, drugs reimbursement scenarios and other studies.
Bio-Pharma Market Coverage
The bio-pharma market is segmented in the following manner:
Drugs By Therapy
The drugs by therapy market is sub-segmented into –
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorders Drugs
- Musculoskeletal Disorders Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
- Vaccines
- Therapeutic Nutrients & Minerals
- Substance Abuse and Addiction
- Intravenous Immunoglobulin
- Pain Management Drugs
- Controlled Release Drug Delivery
- Controlled Substance
- Hepatorenal Syndrome Treatment
- Personalized Medicine
Rare Disease & Orphan Drugs
Drug Usage
- OTC & Prescription
Drug Modality
The drug modality market is sub-segmented into –
- Small Molecules
- Branded and Generics
- Biologics & Biosimilars
- mAb’s
- Bispecific mAbs
- Conjugated mAbs
- Therapeutic Proteins
- Recombinant Proteins
- Interferons
- Interleukins
- Vaccines
- Paediatric & Adult Vaccines
- Gene/Cell Therapy
- Viral Based
- Non-Viral Based (liposomes)
- mAb’s
Contact Us For Your Custom Needs
Contact Us